June 11, 2026 · The Journal of clinical endocrinology and metabolism · DOI: 10.1210/clinem/dgag228

Cardiovascular effects of metyrapone treatment in patients with mild autonomous cortisol secretion: a secondary analysis

Listen to this summary

This study investigates the cardiovascular effects of metyrapone treatment in patients with mild autonomous cortisol secretion (MACS), specifically examining its impact on blood pressure, cardiac fat depots, and other cardiovascular risk factors. The results indicate that metyrapone treatment significantly reduced both systolic and diastolic blood pressure and decreased epicardial fat, while no changes were observed in cardiac function or morphology. Overall, the findings suggest that cortisol-lowering therapy may improve cardiovascular health in patients with MACS.

Helena Niziolek, Ivica Just, Clemens Baumgartner, Anna Tosin, Hansjörg Habisch, Paul Fellinger, Hannes Beiglböck, Michael Poledniczek, Luise Bellach, Anton Luger, Alexandra Kautzky-Willer, Siegfried Trattnig, Maximilian Zeyda, Thomas Scherer, Marie Helene Schernthaner-Reiter, Florian W Kiefer, Greisa Vila, Andreas Kammerlander, Tobias Madl, Michael Leutner, Martin Krssak, Michael Krebs, Peter Wolf

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play